It’s not often that NBA rookies are able to make a positive impact for their squads in Year 1, much less do it as one of the top scoring options. But No. 6 over ...

July 15 has been a whirlwind. While Texas Longhorns head coach Steve Sarkisian and three of his players on his team take on the 2025 SEC Media Days in Atlanta, ...

A lawyer representing an alleged drug “kingpin” stood before a federal judge Wednesday and offered a mea culpa for the ...

A former surgical sales representative who pleaded guilty in January to defrauding the James H. Quillen VA Medical Center was sentenced on Wednesday. Eric Smith, 54, ...

Beaver tails, corn, ice cream, bags of ice and more are purchased by attendees throughout the Johnson County 4-H & ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Key Takeaways The S&P 500 ticked 0.3% higher on Wednesday, July 16, 2025, as President Trump addressed concerns that a dismissal of Fed Chair Jerome Powell could be imminent.Johnson & Johnson shares ...

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

Discover Johnson & Johnson's Q2 2025 earnings insights with raised guidance and strategic growth in Oncology & MedTech.

Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised ...

Johnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, marking J&J's re-entry into the neuroscience field. The stock is still not ...